Pharmaceutical formulations comprising 1-(beta-D-glucopyranosyl)-2-thienylmethylbenzene derivatives as inhibitors of SGLT

Pharmaceutical formulations comprising 1-(beta-D-glucopyranosyl)-2-thienylmethylbenzene derivatives as inhibitors of SGLT

The present invention relates to formulations including compounds of Formula (1), (Formula (1)) or prodrug, or a pharmaceutically acceptable salt thereof. [FIG 1] a:T FIG. 1A | 9000- o 5mg/mL Nanosuspension o 8000- o 4x25mg tablets E 7000- A 100mg tablet 6000- c_ 5000 o 30000E 2000 80 48 1216 20 24...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JOSEPH, THOMAS C, WANG, WENHUA, OUTWIN, TODD
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention relates to formulations including compounds of Formula (1), (Formula (1)) or prodrug, or a pharmaceutically acceptable salt thereof. [FIG 1] a:T FIG. 1A | 9000- o 5mg/mL Nanosuspension o 8000- o 4x25mg tablets E 7000- A 100mg tablet 6000- c_ 5000 o 30000E 2000 80 48 1216 20 24 28 32 36 40 44 48 Time (h) So100000 o 5mg/mL Nanosuspension o 4x25mg tablets A 100mg tablet u 10000 co o 10 .. 0 4 8 12 16 20 24 28 32 36 40444 Time (h)